Heres the key insight: amylin and GLP-1 suppress appetite through complementary but non-overlapping pathways
Amylin is a hormone that is, similar to insulin, secreted by the pancreas
Therefore, it can be administered as a weekly subcutaneous injection
My take is slightly different, as a public health professor and as someone who has trained as a personal trainer and seen up close that weight loss is harder for some people than for others
It is reasonable to expect that easy access to Zepbound will be followed by easy access to other GLP-1 drugs from other companies
And if you notice consistently more pain, deeper bruising, or stronger side effects when injecting in the thigh or arm, switch to abdomen-only injections and discuss alternative sites with your provider